Literature DB >> 22337159

Osteoclast stimulatory transmembrane protein and dendritic cell–specific transmembrane protein cooperatively modulate cell–cell fusion to form osteoclasts and foreign body giant cells.

Hiroya Miyamoto1, Takayuki Suzuki, Yoshiteru Miyauchi, Ryotaro Iwasaki, Tami Kobayashi, Yuiko Sato, Kana Miyamoto, Hiroko Hoshi, Kazuaki Hashimoto, Shigeyuki Yoshida, Wu Hao, Tomoaki Mori, Hiroya Kanagawa, Eri Katsuyama, Atsuhiro Fujie, Hideo Morioka, Morio Matsumoto, Kazuhiro Chiba, Motohiro Takeya, Yoshiaki Toyama, Takeshi Miyamoto.   

Abstract

Cell–cell fusion is a dynamic phenomenon promoting cytoskeletal reorganization and phenotypic changes. To characterize factors essential for fusion of macrophage lineage cells, we identified the multitransmembrane protein, osteoclast stimulatory transmembrane protein (OC-STAMP), and analyzed its function. OC-STAMP–deficient mice exhibited a complete lack of cell–cell fusion of osteoclasts and foreign body giant cells (FBGCs), both of which are macrophage-lineage multinuclear cells, although expression of dendritic cell specific transmembrane protein (DC-STAMP), which is also essential for osteoclast/FBGC fusion, was normal. Crossing OC-STAMP–overexpressing transgenic mice with OC-STAMP–deficient mice restored inhibited osteoclast and FBGC cell–cell fusion seen in OC-STAMP–deficient mice. Thus, fusogenic mechanisms in macrophage-lineage cells are regulated via OC-STAMP and DC-STAMP.
© 2012 American Society for Bone and Mineral Research.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22337159     DOI: 10.1002/jbmr.1575

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  51 in total

1.  Conditional Disruption of miR17~92 in Osteoclasts Led to Activation of Osteoclasts and Loss of Trabecular Bone In Part Through Suppression of the miR17-Mediated Downregulation of Protein-Tyrosine Phosphatase-oc in Mice.

Authors:  Kin-Hing William Lau; Virginia M Stiffel; Charles H Rundle; Mehran Amoui; Jordan Tapia; Tyler D White; Matilda H-C Sheng
Journal:  JBMR Plus       Date:  2017-08-01

2.  Phosphoglycerol dihydroceramide, a distinctive ceramide produced by Porphyromonas gingivalis, promotes RANKL-induced osteoclastogenesis by acting on non-muscle myosin II-A (Myh9), an osteoclast cell fusion regulatory factor.

Authors:  Hiroyuki Kanzaki; Alexandru Movila; Rayyan Kayal; Marcelo H Napimoga; Kenji Egashira; Floyd Dewhirst; Hajime Sasaki; Mohammed Howait; Ayman Al-Dharrab; Abdulghani Mira; Xiaozhe Han; Martin A Taubman; Frank C Nichols; Toshihisa Kawai
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2017-01-31       Impact factor: 4.698

Review 3.  Molecular and cellular basis of bone resorption.

Authors:  Reinhard Gruber
Journal:  Wien Med Wochenschr       Date:  2014-09-16

4.  Tumor necrosis factor receptor-associated factor 6 is required to inhibit foreign body giant cell formation and activate osteoclasts under inflammatory and infectious conditions.

Authors:  Akihito Oya; Eri Katsuyama; Mayu Morita; Yuiko Sato; Tami Kobayashi; Kana Miyamoto; Toru Nishiwaki; Atsushi Funayama; Yoshinari Fujita; Takashi Kobayashi; Morio Matsumoto; Masaya Nakamura; Arihiko Kanaji; Takeshi Miyamoto
Journal:  J Bone Miner Metab       Date:  2017-12-22       Impact factor: 2.626

5.  Muscle paralysis induces bone marrow inflammation and predisposition to formation of giant osteoclasts.

Authors:  Brandon J Ausk; Leah E Worton; Kate S Smigiel; Ronald Y Kwon; Steven D Bain; Sundar Srinivasan; Edith M Gardiner; Ted S Gross
Journal:  Am J Physiol Cell Physiol       Date:  2017-08-30       Impact factor: 4.249

6.  Interleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.

Authors:  Eri Katsuyama; Hiroya Miyamoto; Tami Kobayashi; Yuiko Sato; Wu Hao; Hiroya Kanagawa; Atsuhiro Fujie; Toshimi Tando; Ryuichi Watanabe; Mayu Morita; Kana Miyamoto; Yasuo Niki; Hideo Morioka; Morio Matsumoto; Yoshiaki Toyama; Takeshi Miyamoto
Journal:  J Biol Chem       Date:  2014-11-17       Impact factor: 5.157

7.  Cell-surface phosphatidylserine regulates osteoclast precursor fusion.

Authors:  Santosh K Verma; Evgenia Leikina; Kamran Melikov; Claudia Gebert; Vardit Kram; Marian F Young; Berna Uygur; Leonid V Chernomordik
Journal:  J Biol Chem       Date:  2017-11-03       Impact factor: 5.157

8.  Low-density lipoprotein receptor deficiency causes impaired osteoclastogenesis and increased bone mass in mice because of defect in osteoclastic cell-cell fusion.

Authors:  Mari Okayasu; Mai Nakayachi; Chiyomi Hayashida; Junta Ito; Toshio Kaneda; Masaaki Masuhara; Naoto Suda; Takuya Sato; Yoshiyuki Hakeda
Journal:  J Biol Chem       Date:  2012-04-12       Impact factor: 5.157

9.  OC-STAMP promotes osteoclast fusion for pathogenic bone resorption in periodontitis via up-regulation of permissive fusogen CD9.

Authors:  Takenobu Ishii; Montserrat Ruiz-Torruella; Atsushi Ikeda; Satoru Shindo; Alexandru Movila; Hani Mawardi; Abdullah Albassam; Rayyan A Kayal; Ayman A Al-Dharrab; Kenji Egashira; Wichaya Wisitrasameewong; Kenta Yamamoto; Abdulghani I Mira; Kenji Sueishi; Xiaozhe Han; Martin A Taubman; Takeshi Miyamoto; Toshihisa Kawai
Journal:  FASEB J       Date:  2018-03-13       Impact factor: 5.191

Review 10.  Recent advances in osteoclast biology.

Authors:  Takehito Ono; Tomoki Nakashima
Journal:  Histochem Cell Biol       Date:  2018-02-01       Impact factor: 4.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.